Geode Capital Management, LLC Eq Rx, Inc. Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.66 - $2.31 $830,043 - $1.16 Million	500,026 Added 8.52%	6,371,086 $14.1 Million
Q2 2023 Aug 11, 2023	BUY	$1.61 - $1.96 $2.39 Million - $2.91 Million	1,485,912 Added 33.89%	5,871,060 $10.9 Million
Q1 2023 May 15, 2023	BUY	$1.8 - $2.83 $331,691 - $521,492	184,273 Added 4.39%	4,385,148 $8.51 Million
Q4 2022 Feb 13, 2023	BUY	$2.05 - $5.5 $191,736 - $514,415	93,530 Added 2.28%	4,200,875 $10.3 Million
Q3 2022 Nov 14, 2022	BUY	$0.94 - $5.99 $570,026 - $3.63 Million	606,411 Added 17.32%	4,107,345 $20.3 Million
Q2 2022 Aug 12, 2022	BUY	$3.2 - $5.69 $3.76 Million - $6.69 Million	1,175,790 Added 50.57%	3,500,934 $16.4 Million
Q1 2022 May 13, 2022	BUY	$2.8 - $7.39 $6.26 Million - $16.5 Million	2,237,082 Added 2540.35%	2,325,144 $9.6 Million
Q4 2021 Feb 11, 2022	BUY	$5.92 - $9.98 $521,327 - $878,858	88,062 New	88,062 $600,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.